tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market

Pharma Mar SA (PHMMF) Financial Statements

Compare
58 Followers

Pharma Mar SA Financial Overview

Pharma Mar SA's market cap is currently $1.68B. The company's EPS TTM is $4.087911964; its P/E ratio is 19.23; and it has a dividend yield of 1.04%. Pharma Mar SA is scheduled to report earnings on March 2, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 221.39M€ 174.85M€ 158.15M€ 196.34M€ 229.83M
Gross Profit€ 209.13M€ 166.67M€ 148.54M€ 182.70M€ 213.39M
Operating Income€ 40.28M€ 6.47M€ -3.83M€ 44.07M€ 92.45M
EBITDA€ 48.30M€ 21.23M€ 4.55M€ 52.07M€ 104.08M
Net Income€ 74.99M€ 26.13M€ 1.14M€ 49.36M€ 92.86M
Balance Sheet
Cash & Short-Term Investments€ 167.22M€ 154.53M€ 162.56M€ 182.42M€ 201.88M
Total Assets€ 395.08M€ 349.64M€ 340.52M€ 393.26M€ 368.39M
Total Debt€ 50.55M€ 51.08M€ 43.67M€ 42.63M€ 49.33M
Net Debt€ 32.73M€ -12.16M€ -16.36M€ -107.18M€ -64.02M
Total Liabilities€ 142.53M€ 141.28M€ 147.08M€ 170.30M€ 190.47M
Stockholders' Equity€ 251.83M€ 208.36M€ 193.44M€ 222.96M€ 177.92M
Cash Flow
Free Cash Flow€ 43.75M€ -9.48M€ -29.40M€ 29.47M€ 17.87M
Operating Cash Flow€ 53.13M€ 6.03M€ -13.45M€ 38.32M€ 25.68M
Investing Cash Flow€ -60.79M€ 1.03M€ -43.05M€ 10.88M€ 18.47M
Financing Cash Flow€ -36.52M€ -5.35M€ -32.14M€ -13.37M€ -27.41M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

Pharma Mar SA Debt to Assets

Pharma Mar SA Cash Flow

Pharma Mar SA Forecast EPS vs Actual EPS